Provided by Tiger Fintech (Singapore) Pte. Ltd.

Satsuma Pharmaceuticals, Inc.

1.10
0.0000
Volume:- -
Turnover:1.94M
Market Cap:36.47M
PE:-0.55
High:1.10
Open:1.10
Low:1.10
Close:1.10
Loading ...

Company Profile

Company Name:
Satsuma Pharmaceuticals, Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Satsuma Pharmaceuticals, Inc., a development-stage biopharmaceutical company, develops novel therapeutic products for the acute treatment of migraines. The company's product candidature includes STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which can be self-administered with proprietary pre-filled, single-use, and nasal delivery device. Satsuma Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.